Bird & Bird scoops Eight Awards at the LMG Life Sciences Awards EMEA 2024

Bird & Bird was one of the most successful firms of the night, taking home the following awards which recognised their exceptional work in patent litigation and high-profile corporate transactions:

• Impact Deal of the Year: Envision Pharma acquisition of OKRA.ai 
  
• Impact Case of the Year: Edwards Lifesciences v Meril Life Sciences 
  
• Impact Case of the Year: Abbott Diabetes v Dexcom 
  
• Impact Case of the Year: Xolair Litigations
  
• Impact Case of the Year: Stelara Litigations
  
• Impact Case of the Year: Gilead v Nucana 
  
• Impact Case of the Year: Joined cases C-438/21, C-439/21, & C-440/21
  
• Netherlands Firm of the Year.

The Impact Case and Deal awards are particularly highly regarded as they look to recognise firms and inhouse teams that have been involved in the more impactful case decisions and/or transactions within the life sciences industry from the previous calendar year.

To view the full list of awards and winners please click here.

The LMG Life Sciences Awards EMEA aim to recognise the most impactful, innovative and complex legal work carried out in the Life Sciences sector across a variety of different practice areas.